Mahani Sahar, DiCaro Michael V, Tak Nadia, Hartnett Sigurd, Cyrus Tillman, Tak Tahir
Department of Cardiovascular Medicine, Kirk Kerkorian SOM at the University of Nevada, Las Vegas, Nevada.
Department of Internal Medicine, Kirk Kerkorian SOM at the University of Nevada, Las Vegas, Nevada.
Int J Angiol. 2024 Jul 8;33(4):250-261. doi: 10.1055/s-0044-1787652. eCollection 2024 Dec.
Venous thromboembolism (VTE) is the third most common cause of death worldwide even though incidence rates differ globally. Western nations report 1 to 2 cases per 1,000 person-years, while Eastern countries exhibit lower rates (<1 per 1,000 person-years). This comprehensive review delves into diverse VTE risk factors including gender, diabetes, obesity, smoking, genetic mutations, hormonal influences, travel, infections, trauma, and cancer. Notably, VTE incidence is highest in certain cancers (such as pancreatic, liver, and non-small-cell lung cancers) and lowest in others (such as breast, melanoma, and prostate cancers). The extensive review provides essential information about prevalent factors and explores potential molecular mechanism contributing to VTE.
静脉血栓栓塞症(VTE)是全球第三大常见死因,尽管其发病率在全球范围内存在差异。西方国家报告的发病率为每1000人年1至2例,而东方国家的发病率较低(每1000人年<1例)。这篇综述深入探讨了多种VTE风险因素,包括性别、糖尿病、肥胖、吸烟、基因突变、激素影响、旅行、感染、创伤和癌症。值得注意的是,VTE发病率在某些癌症(如胰腺癌、肝癌和非小细胞肺癌)中最高,而在其他癌症(如乳腺癌、黑色素瘤和前列腺癌)中最低。这篇广泛的综述提供了有关常见因素的重要信息,并探讨了导致VTE的潜在分子机制。